Table of Contents
1. Executive Summary
2. Global Drug Discovery Services Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2017 to 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Drug Discovery Services Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Drug Discovery Services Market by Process
3.3.1: Target Selection
3.3.2: Target Validation
3.3.3: Hit-to-Lead Identification
3.3.4: Lead Optimization
3.3.5: Candidate Validation
3.4: Global Drug Discovery Services Market by Type
3.4.1: Chemistry Services
3.4.2: Biology Services
3.5: Global Drug Discovery Services Market by Drug Type
3.5.1: Small-molecule Drugs
3.5.2: Biologics
3.6: Global Drug Discovery Services Market by Therapeutic Area
3.6.1: Oncology
3.6.2: Neurology
3.6.3: Cardiovascular Diseases
3.6.4: Respiratory Diseases
3.6.5: Diabetes and Other Therapeutic Areas
3.7: Global Drug Discovery Services Market by End Users
3.7.1: Pharmaceutical & Biotechnology Companies
3.7.2: Academic Institutes
3.7.3: Others
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
4.1: Drug Discovery Services Market by Region
4.2: North American Drug Discovery Services Market
4.2.1: North American Drug Discovery Services Market by Type: Chemistry Services and Biology Services
4.2.2: North American Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
4.3: European Drug Discovery Services Market
4.3.1: European Drug Discovery Services Market by Type: Chemistry Services and Biology Services
4.3.2: European Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
4.4: APAC Drug Discovery Services Market
4.4.1: APAC Drug Discovery Services Market by Type: Chemistry Services and Biology Services
4.4.2: APAC Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
4.5: ROW Drug Discovery Services Market
4.5.1: ROW Drug Discovery Services Market by Type: Chemistry Services and Biology Services
4.5.2: ROW Drug Discovery Services Market by End Users: Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Drug Discovery Services Market by Process
6.1.2: Growth Opportunities for the Global Drug Discovery Services Market by Type
6.1.3: Growth Opportunities for the Global Drug Discovery Services Market by Drug Type
6.1.4: Growth Opportunities for the Global Drug Discovery Services Market by Therapeutic Area
6.1.5: Growth Opportunities for the Global Drug Discovery Services Market by End Users
6.1.6: Growth Opportunities for the Global Drug Discovery Services Market by Region
6.2: Emerging Trends in the Global Drug Discovery Services Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Drug Discovery Services Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug Discovery Services Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Eurofins Scientific
7.2: Evotec SE
7.3: Charles River Laboratories International
7.4: GenScript
7.5: Thermo Fisher Scientific
7.6: Oncodesign Services
7.7: ChemPartner Co.
7.8: DiscoverX Corp.
7.9: QIAGEN
7.10: Domainex Ltd